Honorable Brad Buckley, Chair, House Committee on Public Education
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
HB2891 by Talarico (relating to the use of glucagon medication on certain public and private school campuses.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
It is assumed that districts choosing to implement provisions of the bill may incur costs for the maintenance, storage, and disposal of glucagon medication.
Source Agencies:
529 Health and Human Services Commission, 701 Texas Education Agency